Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Joseph Parkhill"


4 mentions found


As inflation concerns remain at the forefront of investors' minds, UBS is eyeing stocks that can find growth no matter the economic cycle. "We define compounders as all-weather stocks that leverage operational excellence and competitive advantages to grow through any phase of the economic cycle," analyst Joseph Parkhill wrote on Tuesday. S & P 500 stocks are trading near all-time high valuations of 20 times price to earnings and 14 times enterprise value/EBITDA, Parkhill said. Here's a look at some of the 17 stocks that UBS is watching. Stocks also on the UBS list include artificial intelligence plays Microsoft and Broadcom .
Persons: Joseph Parkhill, Parkhill, AMZN, Stephen Ju, Jay Sole, Stocks Organizations: UBS, Amazon, Microsoft, Broadcom
Small-cap stocks have had a shaky start in 2024, but UBS thinks the sector is worth looking at as a potential broader market rally could boost the sector. Year to date, the Russell 2000 index of small companies is up 2% while the S & P 500 has gained 6.6%. "We view the expectations around interest rates coming down as incrementally a more supportive backdrop for SMID stocks," UBS analyst Joseph Parkhill wrote in a note last week, referring to small- to mid-cap stocks. With these factors in mind, UBS analysts compiled their list of high conviction, small- and mid-cap names which the bank believes have a unique investment thesis behind them. U.S.-traded shares of Zurich-based On have surged more than 22% in 2023, bringing the past 12 months' rally to 45%.
Persons: Russell, Joseph Parkhill, Roger Federer, Jay Sole, Brody Preston, Preston, WAL, Joshua Chan, There's, — CNBC's Michael Bloom Organizations: UBS, Federal, LSEG, Western Alliance Bancorp Locations: ., Zurich, Phoenix, Aramark, Wall
As several macro overhangs weigh on the markets, UBS named its most compelling plays for the rest of 2023. Meta shares have surged more than 117% year to date amid numerous cost-cutting measures, which CEO Mark Zuckerberg termed as the company's " year of efficiency ." Pharmaceutical giant Eli Lilly is another stock UBS thinks can outperform during uncertain times. The bank added that, "Beyond Mounjaro, LLY has a robust pipeline including late-stage Alzheimer's asset donanemab and promising next-generation obesity/T2D assets." UBS thinks the company will continue to benefit from the liquified natural gas backlog, as European countries look for alternatives to Russian gas.
Dividend stocks may be the way to go for investors as a recession becomes more likely, according to UBS. Dividend stocks on average outperformed the market by 4.5% during the 2001, 2008 and 2020 recessions, the bank said. "Dividend stocks can provide a margin of safety during uncertain times." Given this backdrop, UBS highlighted a slew of dividend stocks with big upsides, based on the bank's price targets. Analysts also forecast three-year dividend growth that's at least in the mid-single digits, in addition to sustainable payout ratios.
Total: 4